Hypertension in adults: diagnosis and management (update)
In development [GID-NG10177] Expected publication date: 19 April 2023
In development [GID-NG10177] Expected publication date: 19 April 2023
In development [GID-NG10159] Expected publication date: TBC
In development [GID-NG10120] Expected publication date: 17 June 2021
In development [GID-NG10153] Expected publication date: 20 July 2022
In development [GID-NG10175] Expected publication date: 14 December 2022
In development [GID-NG10070] Expected publication date: 07 April 2021
In development [GID-NG10139] Expected publication date: 06 April 2022
In development [GID-NG10107] Expected publication date: 10 February 2021
In development [GID-NG10097] Expected publication date: TBC
In development [GID-NG10111] Expected publication date: 12 April 2021
In development [GID-NG10182] Expected publication date: 22 June 2022
In development [GID-NG10119] Expected publication date: 25 August 2021
In development [GID-NG10091] Expected publication date: 21 April 2021
In development [GID-NG10174] Expected publication date: 22 March 2023
In development [GID-NG10123] Expected publication date: 09 December 2021
In development [GID-NG10125] Expected publication date: 10 May 2022
In development [GID-NG10150] Expected publication date: 22 June 2022
In development [GID-NG10165] Expected publication date: 23 January 2023
In development [GID-CGWAVE0725] Expected publication date: 12 May 2022
In development [GID-NG10148] Expected publication date: 18 May 2022
In development [GID-NG10151] Expected publication date: 13 June 2022
In development [GID-NG10069] Expected publication date: TBC
In development [GID-NG10100] Expected publication date: 12 March 2021
In development [GID-NG10149] Expected publication date: 08 June 2022
In development [GID-NG10098] Expected publication date: TBC
In development [GID-NG10122] Expected publication date: 08 September 2021
In development [GID-NG10081] Expected publication date: 31 March 2021
In development [GID-NG10082] Expected publication date: 14 October 2021
In development [GID-NG10155] Expected publication date: 25 May 2022
In development [GID-NG10105] Expected publication date: 23 November 2021
In development [GID-NG10170] Expected publication date: 16 March 2022
In development [GID-NG10113] Expected publication date: 19 January 2022
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
This guideline covers the assessment and care of adults who are at risk of or who have cardiovascular disease (CVD), such as heart disease and stroke. It aims to help healthcare professionals identify people who are at risk of cardiovascular problems including people with type 1 or type 2 diabetes, or chronic kidney disease. It describes the lifestyle changes people can make and how statins can be used to reduce their risk.
This guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.
This guideline covers the assessment, investigation and management of tinnitus in primary, community and secondary care. It offers advice to healthcare professionals on supporting people presenting with tinnitus and on when to refer for specialist assessment and management.
This guideline covers mid-life approaches to delay or prevent the onset of dementia, disability and frailty in later life. The guideline aims to increase the amount of time that people can be independent, healthy and active in later life.
This guideline covers the assessment and early management of head injury in children, young people and adults. It promotes effective clinical assessment so that people receive the right care for the severity of their head injury, including referral directly to specialist care if needed.
This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.
This guideline covers assigning recall intervals between oral health reviews that are appropriate to the needs of individual patients. The guideline takes account of the effect of dental checks on: people’s wellbeing, general health and preventive habits; caries incidence and avoiding restorations; periodontal health and avoiding tooth loss; and avoiding pain and anxiety. It aims to improve or maintain patients’ quality of life and reduce morbidity associated with oral and dental disease.
This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.
This guideline covers assessing and managing cancers of the upper aerodigestive tract in people aged 16 and over. These are cancers of the airways of the head and neck, including the mouth, throat, larynx (voicebox) and sinuses. It aims to reduce variation in practice and improve survival.
This guideline covers diagnosing and managing secondary cancers in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition when this cannot be found.
This guideline covers antenatal care for all pregnant women with complex social factors (particularly alcohol or drug misuse, recent migrant or asylum seeker status, difficulty reading or speaking English, aged under 20, domestic abuse). It offers advice on improving access to care, maintaining contact with antenatal carers, and additional information and support for these women.
This guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout). It aims to improve care for people with TLoC by specifying the most effective assessments and recommending when to refer to a specialist.
This guideline covers how organisations, professionals and carers can work together to deliver high quality care, stable placements and nurturing relationships for looked-after children and young people. It aims to help these children and young people reach their full potential and enjoy the same opportunities in life as their peers.
This guideline covers support to help women stop smoking during pregnancy and in the first year after childbirth. It includes identifying women who need help to quit, referring them to stop smoking services and providing intensive and ongoing support to help them stop. The guideline also advises how to tailor services for women from disadvantaged groups in which smoking rates are high.
This guideline covers reducing harm from smoking. It aims to help people, particularly those who are highly dependent on nicotine, who:
This guideline covers the link between body mass index (BMI) and waist circumference and the risk of disease among adults from black, Asian and other minority ethnic groups in the UK. The aim was to determine whether lower cut-off points should be used for these groups as a trigger for lifestyle interventions to prevent conditions such as diabetes, myocardial infarction or stroke.
This guideline covers people living in England with ancestral links to Bangladesh, India, Nepal, Pakistan or Sri Lanka who use traditional South Asian varieties of smokeless tobacco. The aim is to help them stop using tobacco that is placed in the mouth or nose (but not burned). It does not include oral snuff products that are sucked.